Phenotypic and genetic characterization of antimicrobial profiles of helicobacter pylori strains in Cuba

Journal of Health, Population and Nutrition

Volumn 28, Issue 2, 2010, Pages 124-129

  Llanes, Rafael ^a   Soria, Claudia ^a   Nagashima, Shigeo ^b   Kobayashi, Nobumichi ^b   Gala, Angela ^a   Guzmán, Daymi ^a   Feliciano, Onelkis ^a   Valdés, Lidunka ^a   Gutiérrez, Oderay ^a   Fernández, Heriberto ^c   Llop, Alina ^a   Wada, Akihiro ^d  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

Antibiotic resistance; Cuba; Gene mutations; Helicobacter pylori

Indexed keywords

HELICOBACTER PYLORI;

AMOXICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; CUBA; DNA SEQUENCE; DRUG EFFECT; FEMALE; GENETICS; HELICOBACTER PYLORI; HUMAN; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SPECIES DIFFERENCE;

ADULT; AGE FACTORS; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CLARITHROMYCIN; CUBA; DRUG RESISTANCE, BACTERIAL; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEX FACTORS; SPECIES SPECIFICITY; TETRACYCLINE; YOUNG ADULT;

EID: 77952318033     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zhang YY, Xia HH, Zhuang ZH, Zhong J. True re-infection of Helicobacter pylori after successful eradication-worldwide annual rates, risk factors and clinicalimplications. Aliment Pharmacol Ther 2008;29:145-60.
2. Mégraud F. Helicobacter pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004;53:1374-84.
3. Nahar S, Mukhopadhyay AK, Khan R, Ahmad MM, Datta S, Chattopadhyay S et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol 2004;42:4856-9.
4. Romano M, Iovene MR, Russo MI, Rocco A, Salerno R, Cozzolino D et al. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates J Clin Pathol 2008;61:1112-5.
5. González-Carbajal M. Helicobacter pylori el tercer dogma. 1st ed. Barcelona: Doyma, 2004:120-59.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Wayne: Clinical and Laboratory Standards Institute, 2007:134. (M100-S17).
7. Bogaerts P, Berhin C, Nizet H, Glupczynski Y. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Helicobacter 2006;11:441-5.
8. Yang YJ, Wu JJ, Sheu BS, Kao AW, Huang AH. The rdxA gene plays a more major role than frxA gene mutation in high-level metronidazole resistance of Helicobacter pylori in Taiwan. Helicobacter 2004;9:400-7.
9. Wang G, Wilson TJM, Jiang Q, Taylor DE. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob Agents Chemother 2001;45:727-33.
10. Ogawa Y, Fukutomi T, Sugiura K, Kato K, Tohya Y, Akashiet H. Comparison of Akabame virus isolated from sentinel cattle in Japan. Vet Microbiol 2007;124:16-24.
11. Romano M, Marmo A, Cuomo A, De Simone T, Mucherino C, Iovene et al. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. Clin Gastroenterol Hepatol 2003;1:273-8.
12. Lara MC, Cires M, Garcia AJ. Consumo de antimicrobianos en Atención primaria de salud. Rev Cubana Med Gen Integr 2003;19:2-6.
13. Kwon DH, Hulten K, Kato M, Kim JJ, Lee M, El-Zaatari FAK et al. DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother 2001;45:2609-15.
14. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C et al. Antimicrobial resistance, incidence and risk factors among Helicobacter pyloriinfected persons, United States. Emerg Infect Dis 2004;10:1088-94.
15. Posteraro P, Branca G, Sanguinetti M, Ranno S, Cammarota G, Rahimi S et al. Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay. JAC 2006;57:71-8.
16. De Francesco V, Margiotta M, Zullo A, Hassan C, Valle ND, Burattini O et al. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. Aliment Pharmacol Ther 2006;23:429-35.
17. Llanes R, Sosa J, Guzmán D, Llop A, Valdés EA, Martínez I et al. Antimicrobial susceptibility of Neisseria gonorrhoeae in Cuba (1995-1999). Implications for treatment of gonorrhea. Sex Transm Dis 2003;30:10-4.
18. Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F et al. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents 2007;29:389-96.
19. Dore MP, Osato MS, Realdi G, Mura I, Graham DY, Sepulveda AR. Amoxycillin tolerance in Helicobacter pylori. JAC 1999;43:47-54.
20. Moayyedi P, Hunt RH. Helicobacter pylori. Public health implications. Helicobacter 2004;9:67-72.